{"transactions":[{"id":719157,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2026-07-03T00:58:39.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest as of June 30, 2027."}],"balance_after":30000,"derivative":{"exercise_price":1.01,"exercise_date":"2027-06-30","expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-022661","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022661/rdgdoc.xml","form_type":"4"}},{"id":973146,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-12-12T02:55:15.000Z","date":"2018-12-31","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-25-037614","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037614/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-12-11"}},{"id":973145,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-12T02:55:15.000Z","date":"2025-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9091,"price":2.2,"value":20000.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock.  The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20."}],"balance_after":108294,"source":{"system":"sec-edgar","filing":"0001437749-25-037614","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037614/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-12-11"}},{"id":973144,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-12T02:55:15.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.4,"value":20000.0,"ownership":{"direct":true},"balance_after":117385,"source":{"system":"sec-edgar","filing":"0001437749-25-037614","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037614/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-12-11"}},{"id":973143,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-12-11T23:51:43.000Z","date":"2018-12-31","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-25-037591","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037591/rdgdoc.xml","form_type":"4"}},{"id":973142,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-11T23:51:43.000Z","date":"2025-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9091,"price":2.2,"value":20000.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock.  The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20."}],"balance_after":108294,"source":{"system":"sec-edgar","filing":"0001437749-25-037591","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037591/rdgdoc.xml","form_type":"4"}},{"id":973141,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-11T23:51:43.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.4,"value":20000.0,"ownership":{"direct":true},"balance_after":117385,"source":{"system":"sec-edgar","filing":"0001437749-25-037591","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037591/rdgdoc.xml","form_type":"4"}},{"id":1076659,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-08-04T13:13:40.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001437749-25-024499","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024499/rdgdoc.xml","form_type":"4"}},{"id":1076658,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:13:40.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":20115,"price":1.74,"value":35000.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 67,385 shares of common stock on the net exercise of option to purchase 87,500 shares of common stock.  The issuer withheld 20,115 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74."}],"balance_after":67385,"source":{"system":"sec-edgar","filing":"0001437749-25-024499","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024499/rdgdoc.xml","form_type":"4"}},{"id":1076657,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:13:40.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":87500,"price":0.4,"value":35000.0,"ownership":{"direct":true},"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001437749-25-024499","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024499/rdgdoc.xml","form_type":"4"}},{"id":1450696,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-07-22T22:50:53.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0.33,"value":8250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vest on one year anniversary of grant."}],"balance_after":25000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-24-023224","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924023224/rdgdoc.xml","form_type":"4"}},{"id":2290524,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2022-04-27T01:35:22.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":0.75,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-22-009790","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009790/rdgdoc.xml","form_type":"4"}},{"id":2290523,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2022-04-27T01:35:22.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":26666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Granted in settlement of compensation liability for period January 1, 2019 through April 30, 2019"}],"balance_after":26666,"derivative":{"exercise_price":0.5,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":26666},"source":{"system":"sec-edgar","filing":"0001437749-22-009790","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009790/rdgdoc.xml","form_type":"4"}},{"id":3710139,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-03T16:58:40.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"COMMON STOCK","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001091596-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000109159619000004/primary_doc.xml","form_type":"4"}},{"id":3846474,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-08-13T19:18:17.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":87500,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"COMMON STOCK","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001480208-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000148020818000001/primary_doc.xml","form_type":"4"}},{"id":4260206,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2017-07-10T12:59:38.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18750,"derivative":{"exercise_price":1,"exercise_date":"2017-07-01","expiration_date":"2027-05-10","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001480208-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000148020817000004/primary_doc.xml","form_type":"4"}}]}